Eagle becomes an Open PHACTS associate partner
July 18, 2012
CAMBRIDGE, – The Open PHACTS consortium is pleased to announce an Associate Partner relationship with Eagle Genomcis Ltd. (Eagle). Eagle intend to work with the consortium members to interface Open PHACTS with genomics tools (e.g. the Ensembl Browser) and workflows (e.g. eHive/Galaxy), and also facilitate the integration of data from major genomics references databases (e.g. [...]
July 17, 2012
Wolfenbuettel, Germany –– BIOBASE GmbH, a leading provider of expert-curated biological databases, software and services for the life sciences, today announced a strategic collaboration with the Luxembourg Centre for Systems Biomedicine (LCSB). Researchers in Luxembourg will use Genome Trax™ to analyze next generation sequencing variants in clinical diagnostics. In addition, both groups will collaborate to [...]
Idaho Technology Initiates Clinical Study For FilmArray Blood Culture Identification (BCID) Panel
July 17, 2012
SALT LAKE CITY, UT, - Idaho Technology, Inc., a privately held clinical diagnostics company dedicated to providing the world’s fastest, highest-quality instruments for pathogen identification and DNA analysis, today announced it has commenced a clinical trial to evaluate the Company’s FilmArray Blood Culture Identification (BCID) Panel, which is designed to identify the numerous organisms that [...]
RAE Systems Adds Experienced Gas Detection Sales Leader To America’s Sales Management Team
July 17, 2012
SAN JOSE, Calif. –– RAE Systems Inc., a leading developer of gas and radiation detectors for oil and gas, emergency responders, industrial safety, homeland security and environmental remediation, today announced that Ron Unruh will be joining the company as America’s Mesh and Fixed Systems sales manager. Mr. Unruh brings more than 20 years of experience [...]
July 17, 2012
Lexington, KY,-- Transposagen announced that XTN™ site-specific nucleases targeting each gene in the human genome are now available. Utilizing the FLASH™ high-throughput system (FLASH assembly of TALENs for high-throughput genome editing. Nature Biotechnology 30, 460-465 (2012)), Transposagen can produce a site-specific nuclease targeting nearly any gene in any genome with the fastest delivery time in [...]
NETRIX Licenses “Qualiphi” Polymerase to QIAGEN
July 17, 2012
Genetrix, the Spanish biotechnology holding company, through its X-Pol Biotech subsidiary, has signed a global and exclusive licensing agreement for its “Qualiphi” polymerase product with QIAGEN, the global sample and assay technologies company. Qualiphi is a DNA polymerase that was licensed from the Spanish National Research Council (CSIC) in 2010. Due to its unique properties, [...]
Pamela Morley Joins Real Time Genomics as Vice President of Worldwide Commercial Operations
July 17, 2012
Real Time Genomics, Inc., a leading developer of biocompute technology, today announced the appointment of Pamela Jeffers Morley, Ph.D., as Vice President of Worldwide Commercial Operations. As an accomplished life science industry sales executive, Morley adds extensive field operations experience to the management team as it prepares to ramp up its commercial activities. “I am [...]
SJF Participates in Oversubscribed Round in BioSurplus, First Investment for Fund III
July 17, 2012
SJF Ventures announced today it has invested in BioSurplus, a company providing turnkey services for managing the entire life cycle of laboratory instruments in the life sciences industry. SJF’s investment completes BioSurplus’ $2.4 million Series A financing, which also includes KI Investment Holdings. The financing is being used to fund an East Coast expansion into [...]
July 17, 2012
WILMINGTON, MA, --As it continues to increase the global reach of its explosives trace detection equipment, Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced it has received the grant of a new patent by the Patent Office of the Russian [...]
Illumina Introduces NexteraR Exome and Custom Enrichment Sample Preparation Kits
July 17, 2012
SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) today introduced Nextera Exome and Custom Enrichment kits, the Company's latest targeted resequencing solutions offering sample preparation and enrichment in a single, integrated workflow. Leveraging the speed of Nextera technology and supporting the industry's lowest DNA sample input requirements (50 ng), the new kits enable researchers to quickly [...]

